PubRank

Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26141414)

Published in Int J Infect Dis on June 30, 2015

Authors

Hye-Young Wang1, Sunyoung Park2, Dongsup Lee3, Sunghyun Kim4, Geehyuk Kim2, Kwang Hwa Park5, Hyeyoung Lee6

Author Affiliations

1: M&D, Inc., Wonju Eco Environmental Technology Center, Wonju, Gangwon, Republic of Korea.
2: Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, 1 Yonseidae-gil, Wonju, Gangwon, 220-710, Republic of Korea.
3: Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, 1 Yonseidae-gil, Wonju, Gangwon, 220-710, Republic of Korea; Department of Clinical Laboratory Science, Hyejeon College, Hongseong, Chungnam, Republic of Korea.
4: Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan, Busan, Republic of Korea.
5: Department of Pathology, Yonsei University Wonju College of Medicine, Wonju, Gangwon, Republic of Korea.
6: Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, 1 Yonseidae-gil, Wonju, Gangwon, 220-710, Republic of Korea. Electronic address: hyelee@yonsei.ac.kr.

Articles by these authors ⇆

Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Am J Clin Pathol (2015) 0.80

Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay. Int J Clin Oncol (2015) 0.79

Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer. Exp Mol Pathol (2015) 0.78

Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical cancer. Exp Mol Pathol (2017) 0.75

Evaluation of a quantitative RT-PCR assay to detect HER2 mRNA overexpression for diagnosis and selection of trastuzumab therapy in breast cancer tissue samples. Exp Mol Pathol (2014) 0.75